Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Fusion Pharmaceuticals Inc. | Chief Medical Officer | Restricted Stock Units | 0 | $0 | $2.03 | Jun 4, 2024 | Direct |
Fusion Pharmaceuticals Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 0 | Jun 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FUSN | Fusion Pharmaceuticals Inc. | Jun 4, 2024 | 3 | $0 | 4 | Jun 4, 2024 | Chief Medical Officer |
FUSN | Fusion Pharmaceuticals Inc. | Jan 4, 2024 | 2 | $0 | 4 | Jan 5, 2024 | Chief Medical Officer |
FUSN | Fusion Pharmaceuticals Inc. | Nov 7, 2022 | 1 | $0 | 4 | Nov 7, 2022 | Chief Medical Officer |
FUSN | Fusion Pharmaceuticals Inc. | Nov 7, 2022 | 0 | $0 | 3 | Nov 7, 2022 | Chief Medical Officer |